Rating Change
Barclays analysts reiterated a Underweight rating on NOV Inc. (NYSE:NOV) on July 31, 2026.
Rating Change Barclays analysts reiterated a Underweight rating on NOV Inc. (NYSE:NOV) on July 31, 2026. Market Context NOV Inc.

Barclays analysts reiterated a Underweight rating on NOV Inc. (NYSE:NOV) on July 31, 2026.
NOV Inc. operates in the Energy sector. The stock currently trades at $19.43 with a market capitalization of $6.1B.
Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for NOV Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 2 Buy, 6 Hold, 2 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 31, 2026 | Barclays | Underweight | N/A |
| Jul 30, 2026 | TD Cowen | Buy | N/A |
| Jul 30, 2026 | Susquehanna | Positive | N/A |
| Jul 08, 2026 | Susquehanna | Positive | N/A |
| Jun 18, 2026 | Citigroup | Neutral | N/A |
Related Tools: Analyst Ratings Dashboard | View NOV Stock Page
A Underweight rating from Barclays reflects the analyst's outlook on NOV Inc. (NYSE:NOV). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the NOV forecast page.
Current market data
NYSE · NOV
Keep reading
sec_filing ·
sec_filing ·
analyst ·
earnings ·